date,title,source
Oct-17-18,"Research Report Identifies Oxford Immunotec Global, Ascena Retail Group, Groupon, Epizyme, Regulus Therapeutics, and B Communications with Renewed Outlook  Fundamental Analysis, Calculating Forward Movement",GlobeNewswire
Oct-18-18,Regulus Regains Compliance with NASDAQ Listing Requirements,PR Newswire
Oct-22-18,Regulus to Present Preclinical Data Supporting RGLS4326 as a Novel Therapeutic in Development for Autosomal Dominant Polycystic Kidney Disease at ASN's Kidney Week 2018,PR Newswire
